Hysteroscopy Procedures Market Size, Share & Trends Analysis Report By End-User (Hospitals, Clinics, Ambulatory Surgery Centers) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Hysteroscopy Procedures Market Size

The global hysteroscopy procedures market size was valued at USD 9.98 billion in 2025 and is projected to grow from USD 10.63 billion in 2026 to USD 17.55 billion by 2034, registering a CAGR of 6.47% during the forecast period from 2026 to 2034. North America dominated the hysteroscopy procedures market with a market share of 38.4% in 2025.

Due to the factors such as increasing prevalence of gynecological disorders and rise in adoption of minimally invasive surgical procedures, the hysteroscopy procedures market demand is expected to significantly drive by 2031. Hysteroscopy is a procedure that enables a surgeon to examine the interior of the uterus to diagnose and treat abnormal bleeding. The primary purpose of hysteroscopy is to diagnose and treat abnormal uterine bleeding, excessive menstrual bleeding, irregular spotting between periods, and menopausal bleeding. During hysteroscopy, a narrow, illuminated device called a hysteroscope is placed into the vagina to inspect the cervix and uterus contents. Using operative hysteroscopy, polyps, fibroids, and adhesions can be removed.

Hysteroscopy can further be classified into types; diagnostic hysteroscopy and operative hysteroscopy. The diagnostic hysteroscopy identifies uterine structural abnormalities that may be causing abnormal bleeding. Hysteroscopy may also validate the results of other diagnostic procedures, such as an ultrasound or hysterosalpingography (HSG). An abnormality detected during a diagnostic hysteroscopy is treated during operative hysteroscopy. Hysteroscopy is regarded as a safe procedure. In less than 1% of cases involving hysteroscopy, complications occur.

End-User Insights

The market is segmented into hospitals, clinics, and ambulatory surgery centers. The hospital segment owns the highest market share and is estimated to exhibit a CAGR of 6.4% during the forecast period. The increasing incidence of diseases such as uterine fibroids, endometriosis, and gynecological cancers (ovarian, cervical, uterine, etc.) and a growing number of gynecology surgical procedures contribute to segment growth. Operative hysteroscopy is performed in hospitals to correct any abnormal condition detected during diagnostic hysteroscopy. It can be performed after diagnosis, surpassing the need for a second surgery. Moreover, increasing installations of surgical robots such as the da Vinci Surgical System in hospital settings and rising efforts to lower the work burden on surgeons and co-workers are factors driving segment growth. This robotic-assisted system can be used for various minimally invasive gynecologic procedures, including hysteroscopic myomectomies, polypectomies, endometrial ablation, or other associated conditions. Therefore, the number of patients preferring noninvasive treatment is expected to significantly increase the adoption of gynecology robotic surgeries in hospitals.

An increasing number of specialty clinics, especially for women's health treatment, and the consequent rise in surgical procedures will likely boost segment growth during the forecast period. For instance, in June 2015, Sakra World Hospital launched Sakra Hysteroscopy Clinic, a joint venture among SECOM Hospitals of Japan, Toyota Tsuho Corporation, and Kirloskar. This clinic was established to conduct diagnostic tests and minimally invasive procedures for abnormal uterine bleeding and treatment for polyps, fibroids, miscarriages, and endometrial ablation. Similarly, a collaborative hysteroscopy clinic was launched in 2015 by Mayo Clinic to improve the management of patients with abnormal uterine bleeding and the use of hysteroscopy in a general gynecology practice setting. Thus, increasing hysteroscopes for abnormal uterine bleeding, fertility examinations, and transcervical sterilizations is responsible for segment growth.

Outpatient (ambulatory) hysteroscopy is performed in an appropriately equipped and staffed treatment room outside of the formal setting of an operating room. This provides patient comfort and decreases diagnostic hysteroscopy time requirements. Due to the setup's inclusion of an examination room and lack of the need for an additional operating suite, it is also practical and affordable for both patients and surgeons. Furthermore, recent advancements in technology and instrumentation, like the use of integrated, portable, battery-operated imaging and bettering pain management to make hysteroscopy less painful and invasive, make it simple to perform procedures in ambulatory settings.

Most hospitals now provide ambulatory diagnostic hysteroscopy services to aid in managing abnormal uterine bleeding or to remove a polyp seen on a scan. Therefore, such see-and-treat approaches have shifted gynecological procedures from inpatient to outpatient. Increasing reimbursement for ambulatory hysteroscopy procedures, combined with the proliferation of ambulatory surgery centers, encourages patients to seek care at these facilities.

Request Customizationto receive a tailored report.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global market shareholder and is anticipated to exhibit a CAGR of 6.6% during the forecast period. The existence of important market players, increasing product approval and commercialization, and increased awareness regarding the accessibility of diagnostic tests and treatments all contributed to the expansion of the North American market. Moreover, increasing investments in gynecological system R&D and surging demand for minimally invasive procedures are among the factors driving market expansion in the area. For instance, the Luminelle DTx Hysteroscopy System by UVision360 was given FDA approval in August 2018 for both hysteroscopy and cystoscopy. The system enables medical professionals to conduct hysteroscopic procedures in-office, such as biopsies, and find abnormal tissue growth. As a result, strong distribution channels, easy access to healthcare technologies, and competition among major players regarding product innovation all contribute to the market growth in this area.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Hysteroscopy Procedures Market Trends

Europe is predicted to exhibit a CAGR of 6.02% over the forecast period. Europe accounted for the second most significant market share of the market after North America and is anticipated to exhibit significant growth over the forecast period. This region is one of the most developed globally, with advanced technologies and infrastructure, resulting in many healthcare facilities and quality patient care. The increasing prevalence of disorders, such as uterine fibroids, polyps, cervical cancer, abnormal vaginal bleeding, the rising number of surgical procedures, various key players, and the introduction of cutting-edge products in Europe contribute to market growth. The high share of Europe's hysteroscopy procedures market is also attributed to factors such as high disposable income brought on by the existence of developed economies, the accessibility of well-established healthcare infrastructure, and the availability of skilled professionals.

Asia Pacific Hysteroscopy Procedures Market Trends

The Asia-Pacific hysteroscopy procedures market will probably be driven by improving reimbursement scenarios, growing medical tourism, and advancing technology. Several factors, including the large patient base and the growing demand for technologically sophisticated and affordable healthcare solutions, are also anticipated to create significant growth opportunities in the market. The expansion of clinical trials and significant R&D expenditures by international market players to access underserved markets in the Asia-Pacific region are key market drivers with a significant impact. Additionally, it is anticipated that the number of surgeries and the incidence of diseases related to women's health will rise over the forecast period. Some of the Asia Pacific's emerging economies include Singapore and South Korea.

Latin America is estimated to develop significantly over the forecast period. Rapidly developing economies such as Brazil and Mexico are primarily driving the growth of the Latin American hysteroscopy procedures market. Geographical proximity to the U.S., increasing medical tourism from North America due to affordable healthcare facilities, rising prevalence of chronic diseases, and growing availability of new technologies are some of the major factors propelling the market growth. Moreover, the increasing incidence of gynecological disorders and the rising number of consequent surgeries fuel the market growth. In addition, governments of various nations in the region are striving to improve healthcare infrastructure. Hence, an increase in the number of patients seeking safer healthcare solutions is likely to drive the market in the region.

The Middle East and Africa hysteroscopy procedures market is predicted to develop substantially over the forecast period due to the growing regional healthcare expenditure. In Middle Eastern countries, government organizations cover almost 70% of the healthcare expenditure for citizens. High-income countries, such as Saudi Arabia, Israel, and Qatar, are focused on adopting the latest devices in their healthcare systems. In addition, growing health insurance penetration and increasing regional disease burden in these countries are expected to drive market growth. According to the latest data from International Agency for Research on Cancer (IARC), published in the Global Cancer Observatory, over 7,600 women in the MENA region died from cervical cancer in 2018. Therefore, government efforts and developing healthcare infrastructure in the region are expected to further fuel market growth.

List of Key and Emerging Players in Hysteroscopy Procedures Market